Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424.
2Siegel RL, Miller KD, Jemal A. Colorectal cancer mortality rates in adults aged 20 to 54 years in the United States, 1970-2014. JAMA. 2017;318(6):572–4.
PubMed PubMed Central Article Google Scholar
3Bishehsari F, Mahdavinia M, Vacca M, Malekzadeh R, Mariani-Costantini R. Epidemiological transition of colorectal cancer in developing countries: environmental factors, molecular pathways, and opportunities for prevention. World J Gastroenterol. 2014;20(20):6055–72.
PubMed PubMed Central Article Google Scholar
4Helsingen LM, et al. Colorectal cancer screening with faecal immunochemical testing, sigmoidoscopy or colonoscopy: a clinical practice guideline. BMJ. 2019;367:l5515.
5Schoen RE, Weissfeld JL, Trauth JM, Ling BS, Hayran M. A population-based, community estimate of total colon examination: the impact on compliance with screening for colorectal cancer. Am J Gastroenterol. 2002;97(2):446–51.
6Green AR, Peters-Lewis A, Percac-Lima S, Betancourt JR, Richter JM, Janairo MP, et al. Barriers to screening colonoscopy for low-income Latino and white patients in an urban community health center. J Gen Intern Med. 2008;23(6):834–40.
PubMed PubMed Central Article Google Scholar
7Flood D, Chary A, Austad K, Coj M, Lopez W, Rohloff P. Patient navigation and access to Cancer Care in Guatemala. J Glob Oncol. 2018;4:1–3.
8Sanchez-Barriga JJ. Mortality trends and risk of dying from colorectal cancer in the seven socioeconomic regions of Mexico, 2000-2012. Rev Gastroenterol Mex. 2017;82(3):217–25.
9••HA, C., Perfil clínico y manejo médico-quirúrgico de pacientes con diagnóstico de cáncer colorrectal [thesis]. 2009, Universidad de San Carlos de Guatemala: Guatemala. p. 55. One of the most specific study in this topic that shows statistic in Guatemala.
10Corral JE, Arnold LD, Argueta EE, Ganju A, Barnoya J. Clinical preventive services in Guatemala: a cross-sectional survey of internal medicine physicians. PLoS One. 2012;7(10):e48640.
CAS PubMed PubMed Central Article Google Scholar
11Sierra MS, et al. Cancer patterns and trends in Central and South America. Cancer Epidemiol. 2016;44(Suppl 1):S23–42.
12Sierra MS, Forman D. Burden of colorectal cancer in Central and South America. Cancer Epidemiol. 2016;44(Suppl 1):S74–81.
13Pedro Rizo-Ríos AG-R. Felipe Sánchez-Cervantes, Pedro Murguía-Martínez, Trends in cancer mortality in Mexico: 1990-2012. Med J Hospital General de Mexico. 2015;78:85–94.
14Darío Fernando Burbano Luna MAM, García MÁC, Corona TP, Velázquez NNH, Espinoza YME, Urrutia JMG, et al. Epidemiology of colorectal cancer in patients under 50 years old in the Hospital Juárez of México. Endoscopia. 2016;28:160–5.
15Imran JB, Ochoa-Hernandez A, Herrejon J, Madni TD, Clark AT, Huerta S. Surgical approach to gallbladder disease in rural Guatemala. J Surg Res. 2017;218:329–33.
16Imran JB, Ochoa-Hernandez A, Herrejon J, Ortiz C, Mijangos B, Madni T, et al. Barriers to adoption of laparoscopic cholecystectomy in a county hospital in Guatemala. Surg Endosc. 2019;33(12):4128–32.
17Ochoa-Hernandez, A., et al., Emergent groin hernia repair at a County Hospital in Guatemala: patient-related issues vs. health care system limitations. Hernia, 2019.
18Benson AB, Venook AP, al-Hawary MM, Cederquist L, Chen YJ, Ciombor KK, et al. NCCN guidelines insights: colon cancer, version 2.2018. J Natl Compr Cancer Netw. 2018;16(4):359–69.
19Wells KO, Peters WR. Minimally invasive surgery for locally advanced rectal Cancer. Surg Oncol Clin N Am. 2019;28(2):297–308.
20Imran JB, et al. Barriers to adoption of laparoscopic cholecystectomy in a county hospital in Guatemala. Surg Endosc. 2019.
21Argo, M., et al., Current status of local anesthesia for inguinal hernia repair in developing countries and in the United States. Hernia, 2019.
22•Sergio Waldemar Macario Nimatuj, M., Maxi Alexander Méndez Morán, Jorge San José Gómez, Herman De Mata Quinto, José Ricardo Guzmán Villatoro, Cirugía Colorrectal Laparoscópica. Experiencia de los últimos 5 años de un solo Equipo Quirúrgico. Revista Guatemalteca de Cirugia 2018. 24. Demonstrate the lack of experience in minimal invasive approach in this country.
23•HM, C., Aspectos clínicos, abordaje terapéutico y complicaciones más frecuentes en pacientes con diagnóstico de cáncer colorrectal, atendidos en el hospital escuela Roberto Calderón en el periodo del 1ro enero 2013 al 30 junio 2014. 2014, Universidad Nacional Autónoma de Nicaragua: Nicaragua. p. 59. One of the few studies availables in Central America about this topic.
24Tsoi KKF, Hirai HW, Chan FCH, Griffiths S, Sung JJY. Predicted increases in incidence of colorectal cancer in developed and developing regions, in association with ageing populations. Clin Gastroenterol Hepatol. 2017;15(6):892–900 e4.
25Benson AB, Venook A, Al-Hawary MM, Arain MA, Chen YJ, Ciombor KK, et al. NCCN clinical practice guidelines in oncology (NCCN guidelines) rectal Cancer. J Natl Compr Cancer Netw. 2019.
26Matsuda T, Yamashita K, Hasegawa H, Oshikiri T, Hosono M, Higashino N, et al. Recent updates in the surgical treatment of colorectal cancer. Ann Gastroenterol Surg. 2018;2(2):129–36.
PubMed PubMed Central Article Google Scholar
27Polanco PM, Mokdad AA, Zhu H, Choti MA, Huerta S. Association of adjuvant chemotherapy with overall survival in patients with rectal cancer and pathologic complete response following neoadjuvant chemotherapy and resection. JAMA Oncol. 2018;4(7):938–43.
PubMed PubMed Central Article Google Scholar
28Arnold M, Sierra MS, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global patterns and trends in colorectal cancer incidence and mortality. Gut. 2017;66(4):683–91.
29Ginsberg GM, et al. Prevention, screening and treatment of colorectal cancer: a global and regional generalized cost effectiveness analysis. Cost Eff Resour Alloc. 2010;8:2.
PubMed PubMed Central Article Google Scholar
30Issa IA, Noureddine M. Colorectal cancer screening: an updated review of the available options. World J Gastroenterol. 2017;23(28):5086–96.
PubMed PubMed Central Article Google Scholar
31Corter AL, Speller B, McBain K, Wright FC, Quan ML, Kennedy E, et al. Evaluating a multidisciplinary cancer conference checklist: practice versus perceptions. J Multidiscip Healthc. 2019;12:883–91.
PubMed PubMed Central Article Google Scholar
32Varela JE, Asolati M, Huerta S, Anthony T. Outcomes of laparoscopic and open colectomy at academic centers. Am J Surg. 2008;196(3):403–6.
33••Lopez RI, et al. Consensus on management of metastatic colorectal cancer in Central America and the Caribbean: San Jose, Costa Rica, August 2016. ESMO Open. 2018;3(3):e000315 This document includes the formal expert consensus recommendations in various scenarious in colorectal cancer.
PubMed PubMed Central Article Google Scholar
34Serrano PE, Gu CS, Husien M, Jalink D, Ritter A, Martel G, et al. Risk factors for survival following recurrence after first liver resection for colorectal cancer liver metastases. J Surg Oncol. 2019;120(8):1420–6.
35Argo M, Timmerman C, Ochoa-Hernandez A, Ortiz C, Lopez-Huertas V, Huerta S. Current status of local anesthesia for inguinal hernia repair in developing countries and in the United States. Hernia. 2019;23(3):621–2.
CAS PubMed Article Google Scholar
36Timmerman C, Hernandez AO, Ortiz C, Huertas VL, Lopez R, Huerta S. Current view on the nonoperative management of acute appendicitis in a county hospital in Guatemala. J Surg Res. 2019;237:108–9.
37Huerta S, Murray B, Olson C, Patel P, Anthony T. Current evidence-based opinions in the management of adenocarcinoma of the rectum. Indian J Surg. 2009;71(6):356–62.
38Sauer R, Becker H, Hohenberger W, Rödel C, Wittekind C, Fietkau R, et al. Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med. 2004;351(17):1731–40.
CAS PubMed Article Google Scholar
39Rahbari NN, Elbers H, Askoxylakis V, Motschall E, Bork U, Büchler MW, et al. Neoadjuvant radiotherapy for rectal cancer: meta-analysis of randomized controlled trials. Ann Surg Oncol. 2013;20(13):4169–82.
40Song JH, Jeong JU, Lee JH, Kim SH, Cho HM, Um JW, et al. Preoperative chemoradiotherapy versus postoperative chemoradiotherapy for stage II-III resectable rectal cancer: a meta-analysis of randomized controlled trials. Radiat Oncol J. 2017;35(3):198–207.
CAS PubMed PubMed Central Article Google Scholar
41Boland GM, Chang GJ, Haynes AB, Chiang YJ, Chagpar R, Xing Y, et al. Association between adherence to National Comprehensive Cancer Network treatment guidelines and improved survival in patients with colon cancer. Cancer. 2013;119(8):1593–601.
42Grothey A, Sobrero AF, Shields AF, Yoshino T, Paul J, Taieb J, et al. Duration of adjuvant chemotherapy for stage III colon cancer. N Engl J Med. 2018;378(13):1177–88.
CAS PubMed PubMed Central Article Google Scholar
43Twelves C, Wong A, Nowacki MP, Abt M, Burris H 3rd, Carrato A, et al. Capecitabine as adjuvant treatment for stage III colon cancer. N Engl J Med. 2005;352(26):2696–704.
CAS PubMed Article Google Scholar
44Andre T, et al. Three versus 6 months of oxaliplatin-based adjuvant chemotherapy for patients with stage III colon cancer: disease-free survival results from a randomized, open-label, international duration evaluation of adjuvant (IDEA) France, Phase III Trial. J Clin Oncol. 2018;36(15):1469–77.
CAS PubMed Article Google Scholar
45Bregni G, Rebuzzi SE, Sobrero A. The optimal duration of adjuvant therapy for stage III colon cancer: the European perspective. Curr Treat Options in Oncol. 2019;20(1):8.
Comments (0)